daunomycin
简明释义
英[/ˌdɔː.nəˈmaɪ.sɪn/]美[/ˌdɔː.nəˈmaɪ.sɪn/]
n. 正定霉素;[微][药] 道诺霉素;红比霉素;[微] 柔毛霉素
英英释义
Daunomycin is an anthracycline antibiotic used as a chemotherapy medication to treat certain types of cancer, particularly leukemia. | 达诺霉素是一种蒽环类抗生素,用作化疗药物治疗某些类型的癌症,特别是白血病。 |
单词用法
同义词
反义词
正常细胞生长 | 正常的细胞生长对组织修复至关重要。 | ||
健康组织 | 健康的组织能够再生并维持功能。 |
例句
1.It had the anti-mutation function that can inhibit mutagenicity of Daunomycin and Methane Sulfonate in strains TA98 and TA100.
对正定霉素和甲基甲烷磺酸酯所诱发的TA98和TA100菌株的回复突变,具有抗突变作用;
2.AIM: To evaluate the pathologic features of rabbit lens posterior capsule cells under the effect of daunomycin.
目的:观察家兔晶体后囊膜细胞在柔红霉素作用下的组织学及超微结构变化。
3.The products of this process are important intermediates in the synthesis of daunomycin and its analogs which are useful in the therapy of neoplastic ailments.
这一进程的产品是在柔红霉素及其类似物,以期在肿瘤疾病治疗的有效合成的重要中间体。
4.The electrochemical behaviors of daunomycin (DNM) at bare and DNA modified graphite powder microelectrodes have been comparatively studied, and a method for the determination of DNM was developed.
研究了道诺霉素(DNM)在石墨粉末微电极和DNA修饰石墨粉末微电极上的电化学行为,并分析了产生差别的原因。
5.The electrochemical behaviors of daunomycin (DNM) at bare and DNA modified graphite powder microelectrodes have been comparatively studied, and a method for the determination of DNM was developed.
研究了道诺霉素(DNM)在石墨粉末微电极和DNA修饰石墨粉末微电极上的电化学行为,并分析了产生差别的原因。
6.The dosage of daunomycin must be carefully calculated to avoid toxicity.
必须仔细计算达诺霉素的剂量以避免毒性。
7.The oncologist recommended using daunomycin for the treatment of leukemia.
肿瘤科医生建议使用达诺霉素治疗白血病。
8.Research shows that daunomycin can be effective against certain types of cancer.
研究表明,达诺霉素对某些类型的癌症有效。
9.In clinical trials, daunomycin has shown promising results in combination therapies.
在临床试验中,达诺霉素在联合疗法中显示出良好的结果。
10.Patients receiving daunomycin should be monitored for potential side effects.
接受达诺霉素治疗的患者应监测潜在的副作用。
作文
Daunomycin is a powerful chemotherapeutic agent that has been used in the treatment of various types of cancer, particularly leukemia. This drug, derived from the bacterium Streptomyces peucetius, acts by intercalating into DNA and disrupting the replication process of rapidly dividing cells. The significance of daunomycin in oncology cannot be overstated, as it has provided a lifeline for many patients battling aggressive forms of cancer. The history of daunomycin dates back to the 1960s when researchers first isolated it from soil bacteria. Since then, it has undergone extensive studies to determine its efficacy and safety profile. One of the key aspects of daunomycin is its ability to target cancer cells specifically, which makes it a preferred choice in chemotherapy regimens. However, like many chemotherapeutic agents, daunomycin is not without its side effects. Patients undergoing treatment may experience nausea, hair loss, and an increased risk of infection due to its impact on the immune system. Despite these challenges, the development of daunomycin has paved the way for advancements in cancer treatment. Researchers have been working to enhance its effectiveness while minimizing adverse effects. For instance, combining daunomycin with other drugs has shown promising results in improving patient outcomes. Additionally, ongoing studies are exploring the potential of daunomycin in treating solid tumors, expanding its application beyond hematological malignancies. The role of daunomycin in cancer therapy highlights the importance of continued research in pharmacology and oncology. As scientists delve deeper into the mechanisms of action of daunomycin, they uncover new ways to optimize its use, potentially leading to more effective treatment protocols. Furthermore, the insights gained from studying daunomycin can contribute to the development of novel anticancer agents that may one day replace or complement existing therapies. In conclusion, daunomycin stands as a testament to the progress made in cancer treatment over the past few decades. Its discovery marked a turning point in the fight against cancer, offering hope to countless individuals facing this devastating disease. As research continues, it is crucial to remain optimistic about the future of cancer therapy and the role that daunomycin will play in it. By understanding the complexities of this drug and its impact on patient care, we can better appreciate the ongoing efforts to improve the lives of those affected by cancer.
达诺霉素是一种强效的化疗药物,已被用于治疗多种类型的癌症,特别是白血病。这种药物源自于放线菌Streptomyces peucetius,通过插入DNA并破坏快速分裂细胞的复制过程来发挥作用。达诺霉素在肿瘤学中的重要性不容小觑,因为它为许多与侵袭性癌症作斗争的患者提供了生命线。达诺霉素的历史可以追溯到20世纪60年代,当时研究人员首次从土壤细菌中分离出它。从那时起,它经历了广泛的研究,以确定其有效性和安全性特征。达诺霉素的一个关键方面是它能够特异性地靶向癌细胞,这使其成为化疗方案中的首选。然而,像许多化疗药物一样,达诺霉素并非没有副作用。接受治疗的患者可能会经历恶心、脱发和由于对免疫系统的影响而增加感染风险。尽管面临这些挑战,达诺霉素的发展为癌症治疗的进步铺平了道路。研究人员一直在努力增强其效果,同时最小化不良反应。例如,将达诺霉素与其他药物结合使用已显示出改善患者预后的良好结果。此外,正在进行的研究正在探索达诺霉素在治疗实体肿瘤方面的潜力,扩大其应用范围,超越血液恶性肿瘤。达诺霉素在癌症治疗中的角色突显了药理学和肿瘤学持续研究的重要性。随着科学家们深入研究达诺霉素的作用机制,他们发现优化其使用的新方法,从而可能导致更有效的治疗方案。此外,从研究达诺霉素中获得的见解可以为开发新型抗癌药物提供帮助,这些药物未来可能取代或补充现有疗法。总之,达诺霉素是过去几十年癌症治疗进展的见证。它的发现标志着抗击癌症的一个转折点,为无数面临这一毁灭性疾病的个体带来了希望。随着研究的继续,我们必须对癌症治疗的未来以及达诺霉素将在其中发挥的作用保持乐观。通过理解这种药物的复杂性及其对患者护理的影响,我们可以更好地欣赏改善癌症患者生活质量的持续努力。